Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1250 of 1631 entries
View as:

Evaluation of the Irritation Potential of Products in Human Eyes.

Phase: N/A Priority: Normal
NCT ID: NCT02728856 Org: User:
Start: 02/27/16 End: 02/27/16 Due: 02/27/17

Retrospective Claims Analysis of Hysterectomy After Sterilization

Phase: N/A Priority: Normal
NCT ID: NCT02527278 Org: User:
Start: 07/30/15 End: 02/09/16 Due: 02/09/17

Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00975299 Org: User:
Start: 09/30/09 End: 10/31/10 Due: 10/31/11

Moisturizing Effect of Two Dexpanthenol Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00839280 Org: User:
Start: 08/31/07 End: 09/30/07 Due: 09/30/08

Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap

Phase: N/A Priority: Normal
NCT ID: NCT02131662 Org: User:
Start: 05/15/14 End: 05/04/16 Due: 05/04/17

A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test

Phase: N/A Priority: Normal
NCT ID: NCT01740687 Org: User:
Start: 11/13/12 End: 06/14/21 Due: 06/14/22

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04137120 Org: User:
Start: 02/19/21 End: 02/01/23 Due: 02/01/24

Sun Protection Factor (SPF) Efficacy Assay

Phase: N/A Priority: Normal
NCT ID: NCT02885805 Org: User:
Start: 06/26/15 End: 07/01/15 Due: 07/01/16

A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)

Phase: N/A Priority: Normal
NCT ID: NCT04665570 Org: User:
Start: 12/21/20 End: 09/05/24 Due: 09/05/25

A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT06402721 Org: User:
Start: 05/17/24 End: 02/24/25 Due: 02/24/26

A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00359359 Org: User:
Start: 07/31/06 End: 08/31/09 Due: 08/31/10

Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder

Phase: N/A Priority: Normal
NCT ID: NCT01168895 Org: User:
Start: 07/31/10 End: 09/30/10 Due: 09/30/11

A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06655194 Org: User:
Start: 02/26/25 End: 04/06/25 Due: 04/06/26

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04696055 Org: User:
Start: 02/03/21 End: 04/23/24 Due: 04/23/25

An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United States

Phase: N/A Priority: Normal
NCT ID: NCT06363110 Org: User:
Start: 04/10/24 End: 06/24/24 Due: 06/24/25

Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT01098760 Org: User:
Start: 08/31/10 End: 10/31/13 Due: 10/31/14

Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00657033 Org: User:
Start: 10/31/03 End: 08/31/04 Due: 08/31/05

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT00831714 Org: User:
Start: 02/28/09 End: 04/30/13 Due: 04/30/14

Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.

Phase: N/A Priority: Normal
NCT ID: NCT04534465 Org: User:
Start: 02/13/13 End: 03/19/13 Due: 03/19/14

A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05858164 Org: User:
Start: 08/07/23 End: 07/30/25 Due: 07/30/26

Ultravist: Safety and Efficacy in Computed Tomography of Head and Body

Phase: N/A Priority: Normal
NCT ID: NCT00244140 Org: User:
Start: 10/31/05 End: 04/30/08 Due: 04/30/09

Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases

Phase: N/A Priority: Normal
NCT ID: NCT03474757 Org: User:
Start: 02/28/18 End: 07/30/18 Due: 07/30/19

Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT03126747 Org: User:
Start: 06/29/17 End: 11/17/21 Due: 11/17/22

Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02442063 Org: User:
Start: 08/31/15 End: 10/31/16 Due: 10/31/17

A Study to Learn More About How Safe BAY2586116 is, How it Affects the Body, How it Moves Into, Through and Out of the Body at Different Doses in Healthy Japanese Male Participants After Taking Single and Multiple Doses Through the Nose

Phase: N/A Priority: Normal
NCT ID: NCT04872387 Org: User:
Start: 05/11/21 End: 08/26/21 Due: 08/26/22